We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

5 hedge funds and large institutions have $68.3K invested in Nymox Pharmaceutical Corp in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% less capital invested

Capital invested by funds: $287K → $68.3K (-$219K)

86% less funds holding

Funds holding: 36 → 5 (-31)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 31

Holders
5
Holders Change
-31
Holders Change %
-86.11%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFG
Steward Financial Group
Texas
+$24

Top Sellers

Rank Fund Capital Flow
1
CF
Corrigan Financial
Rhode Island
-$57.4K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$38.2K
3
CAN
Cetera Advisor Networks
California
-$22.6K
4
Morgan Stanley
Morgan Stanley
New York
-$18.8K
5
BFG
Bleakley Financial Group
New Jersey
-$15.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
DDC
1
DF Dent & Co
Maryland
$39.4K – – –
FCFC
2
First Citizens Financial Corp
Iowa
$18.4K – – –
CAM
3
Cubic Asset Management
Massachusetts
$5.25K – – –
ODIJL
4
One Day In July LLC
Vermont
$5.25K – – –
CF
5
Corrigan Financial
Rhode Island
– -$57.4K -302,252 Closed
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$38.2K -201,000 Closed
CAN
7
Cetera Advisor Networks
California
– -$22.6K -118,900 Closed
Morgan Stanley
8
Morgan Stanley
New York
– -$18.8K -98,686 Closed
BFG
9
Bleakley Financial Group
New Jersey
– -$15.2K -80,000 Closed
SS
10
Simplicity Solutions
Minnesota
– -$15.2K -80,000 Closed
Renaissance Technologies
11
Renaissance Technologies
New York
– -$12K -60,800 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -$9.63K -50,678 Closed
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$7.96K -41,914 Closed
BlackRock
14
BlackRock
New York
– -$7.35K -38,689 Closed
UBS Group
15
UBS Group
Switzerland
– -$6.56K -34,530 Closed
Brown Advisory
16
Brown Advisory
Maryland
– -$5.32K -28,000 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$4.76K -25,040 Closed
Corient Private Wealth
18
Corient Private Wealth
Florida
– -$4.75K -25,000 Closed
BHWM
19
Beaird Harris Wealth Management
Texas
– -$4.64K -24,400 Closed
Goldman Sachs
20
Goldman Sachs
New York
– -$4.2K -22,084 Closed
Osaic Holdings
21
Osaic Holdings
Arizona
– -$3.88K -20,400 Closed
VF
22
Virtu Financial
New York
– -$4K -20,377 Closed
WP
23
WMS Partners
Maryland
– -$3.42K -18,000 Closed
National Bank of Canada
24
National Bank of Canada
Quebec, Canada
– -$3.27K -17,200 Closed
TSS
25
Two Sigma Securities
New York
– -$2.23K -11,737 Closed
1
2

NYMX Hedge Fund Activity: Q3 2023 in Review

5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2023, worth a combined $68.3K — down 76% from $287K a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of NYMX and 1 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Steward Financial Group, opening a new position worth an estimated $24. The largest seller was Corrigan Financial, exiting entirely with an estimated $57.4K sold.

  • 5 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2023, down from 36 in Q2 2023.
  • Funds reported $68.3K of Nymox Pharmaceutical Corp stock for Q3 2023, down 76% quarter-over-quarter.
  • 1 fund opened new Nymox Pharmaceutical Corp positions in Q3 2023 and 31 closed out, a net change of -30 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q3 2023 was Steward Financial Group, an estimated $24 added.
  • The largest Nymox Pharmaceutical Corp seller in Q3 2023 was Corrigan Financial, an estimated $57.4K sold.

Based on aggregated 13F filings for Q3 2023.